Unlock instant, AI-driven research and patent intelligence for your innovation.
Gliclazide composition freeze-drying tablets and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of freeze-dried tablet and composition, which is applied in the field of gliclazide composition freeze-dried tablet and its preparation, and achieves the effect of improving dissolution rate, large dissolution rate and good formability
Inactive Publication Date: 2015-04-29
HAINAN WEI KANG PHARMA QIANSHAN
View PDF3 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0009] Starch is the basic excipient of oral solid preparations. It is formed by the polymerization of glucose molecules. It is often used as a binder, diluent and disintegrating agent in tablets. It is cheap and easy to obtain, and is safe for the human body. However, starch is used alone as an excipient There is no report on the production of gliclazide freeze-dried tablets by freeze-drying process
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0028]
[0029]
[0030] A. Weigh 100g of cornstarch, add 900ml of purified water and stir, use a pH regulator to control the pH of the solution at 5-7.5, then heat to 72°C and keep for 120 minutes to make 9% (W / V) cornstarch solution.
[0031] B. Measure 45ml of purified water, boil, add 85g of sucrose, stir, after dissolving, continue heating to 100°C, filter with refined cotton, wash the filter with an appropriate amount of hot distilled water, combine the lotion and filtrate, let cool, add Add appropriate amount of distilled water to make the whole volume into 100mL, stir well to obtain B solution.
[0032] C. Mix the solution obtained in step A with the solution obtained in step B, fully stir for 30 minutes, and then lower the solution to normal temperature to obtain a corn-sucrose solution.
[0033] D. Weigh 80 g of gliclazide, add it into 1 L of corn-sucrose solution, and stir for 30 minutes.
[0034] E. After measuring the content of gliclazide in the medicinal...
Embodiment 2
[0037]
[0038] A. Weigh 130g of cornstarch, add 900ml of purified water and stir, use a pH regulator to control the pH of the solution at 5-7.5, then heat to 72°C and keep for 120 minutes to make 13% (W / V) cornstarch solution.
[0039] B. Measure 45ml of purified water, boil, add 85g of sucrose, stir, after dissolving, continue heating to 100°C, filter with refined cotton, wash the filter with an appropriate amount of hot distilled water, combine the lotion and filtrate, let cool, add Add appropriate amount of distilled water to make the whole volume into 100mL, stir well to obtain B solution.
[0040] C. Mix the solution obtained in step A with the solution obtained in step B, fully stir for 30 minutes, and then lower the solution to normal temperature to obtain a corn-sucrose solution.
[0041] D. Weigh 80 grams of gliclazide (calculated as 1000 tablets), add 1L of corn-sucrose solution, and stir for 30 minutes.
[0042] E. After measuring the content of gliclazide in ...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention provides gliclazide composition freeze-drying tablets and a preparation method thereof, and relates to the technical field of medicine and medicine production. The gliclazide composition freeze-drying tablets comprise gliclazide, starch and canesugar; the starch and the canesugar are adopted as auxiliary materials; common corn starch is subjected to heating technology treatment; the adhesion and disintegration function of the starch in the tablets can be improved; the formability of the tablets is improved; the gliclazide composition freeze-drying tablets just need the two auxiliary materials of the starch and the canesugar. The gliclazide composition freeze-drying tablets adopt a reduction for two times and increment for two times technology; temperature reduction for two times and temperature increment for two times enable the formability of the tablets to be better; the dissolution rate of the tablets is improved, so as to improve the bioavailability of the tablets; the tablets overcome the defects of common gliclazide tablets, reduce the kinds and using amount of the auxiliary materials in the gliclazide tablets, are high in dissolution rate and bioavailability, and ensure the curative effect and safety of clinical medication.
Description
technical field [0001] The invention relates to the technical field of medicine and medicine production, in particular to a gliclazide composition freeze-dried tablet and a preparation method thereof. Background technique [0002] This product is a second-generation sulfonylureaoral hypoglycemicdrug, which has hypoglycemic effects on both normal people and diabetic patients. Its hypoglycemic strength is between tolbutamide and glyburide. This product mainly has a direct effect on the pancreas, promoting the transport of Ca++ to the islet β cells, and stimulating the secretion of insulin. At the same time, it can also improve the metabolism of glucose in the surrounding tissues, thereby reducing blood sugar. [0003] In addition, this product can inhibit the release of arachidonic acid from phospholipids in platelets, thereby reducing the synthesis of thromboxane (TXA3), and also inhibiting various coagulation factors (such as V, VIII, XI), and can increase fibrinolysis. ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.